Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ)
CNY 8.16
(0.25%)
CNY 8.16
(0.25%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 47.81 Million CNY | 98.72% |
| 2022 | 24.06 Million CNY | 1.35% |
| 2021 | 23.74 Million CNY | 13.19% |
| 2020 | 20.97 Million CNY | 49.53% |
| 2019 | 14.02 Million CNY | -64.93% |
| 2018 | 40 Million CNY | -20.0% |
| 2017 | 50 Million CNY | 0.0% |
| 2016 | 50 Million CNY | 4999999862.75% |
| 2015 | 1.00 CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | -100.0% |
| 2007 | 5 Million CNY | -87.18% |
| 2006 | 39 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 51.2 Million CNY | 0.0% |
| 2024 Q2 | 43.38 Million CNY | 0.0% |
| 2024 Q1 | 46.16 Million CNY | 0.0% |
| 2023 Q4 | 47.81 Million CNY | 49.81% |
| 2023 FY | 47.81 Million CNY | 98.72% |
| 2023 Q1 | 22.28 Million CNY | -7.4% |
| 2023 Q2 | 27.17 Million CNY | 21.97% |
| 2023 Q3 | 31.91 Million CNY | 17.43% |
| 2022 Q1 | 22.95 Million CNY | -3.3% |
| 2022 Q2 | 22.08 Million CNY | -3.82% |
| 2022 FY | 24.06 Million CNY | 1.35% |
| 2022 Q4 | 24.06 Million CNY | 14.22% |
| 2022 Q3 | 21.06 Million CNY | -4.6% |
| 2021 FY | 23.74 Million CNY | 13.19% |
| 2021 Q1 | 19.73 Million CNY | 0.0% |
| 2021 Q2 | 19.65 Million CNY | -0.41% |
| 2021 Q3 | 19.86 Million CNY | 1.11% |
| 2021 Q4 | 23.74 Million CNY | 19.5% |
| 2020 FY | 20.97 Million CNY | 49.53% |
| 2020 Q3 | 14.01 Million CNY | -0.1% |
| 2020 Q4 | - CNY | -100.0% |
| 2020 Q1 | 14.02 Million CNY | 0.0% |
| 2020 Q2 | 14.02 Million CNY | 0.0% |
| 2019 FY | 14.02 Million CNY | -64.93% |
| 2019 Q4 | 14.02 Million CNY | -49.9% |
| 2019 Q3 | 28 Million CNY | -30.0% |
| 2019 Q2 | 40 Million CNY | 0.0% |
| 2019 Q1 | 40 Million CNY | 0.0% |
| 2018 Q2 | 50 Million CNY | 0.0% |
| 2018 Q4 | 40 Million CNY | 0.0% |
| 2018 Q3 | 40 Million CNY | -20.0% |
| 2018 FY | 40 Million CNY | -20.0% |
| 2018 Q1 | 50 Million CNY | 0.0% |
| 2017 Q1 | 50 Million CNY | 0.0% |
| 2017 FY | 50 Million CNY | 0.0% |
| 2017 Q2 | 50 Million CNY | 0.0% |
| 2017 Q4 | 50 Million CNY | 0.0% |
| 2017 Q3 | 50 Million CNY | 0.0% |
| 2016 FY | 50 Million CNY | 4999999862.75% |
| 2016 Q2 | 105.26 Million CNY | 0.0% |
| 2016 Q4 | 50 Million CNY | -9.23% |
| 2016 Q3 | 55.08 Million CNY | -47.67% |
| 2016 Q1 | - CNY | -100.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q4 | 1.00 CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 FY | 1.00 CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2009 Q3 | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2008 FY | - CNY | -100.0% |
| 2007 FY | 5 Million CNY | -87.18% |
| 2006 FY | 39 Million CNY | 0.0% |